Recombinant HIV-1 gag p17-p24, gp41-gp120

Unlock the power of cutting-edge immunology research with our Recombinant HIV-1 gag p17-p24, gp41-gp120 – a meticulously crafted biochemical reagent that holds the key to unlocking new frontiers in the fight against HIV. This versatile product, identified by the reference number 54-BITP1890, is a testament to the relentless pursuit of scientific excellence.

Crafted with the utmost care and precision, this recombinant protein is a fusion of the HIV-1 gag p17-p24 and gp41-gp120 domains, offering researchers a comprehensive tool for exploring the intricate mechanisms of the HIV virus. Its unique composition allows for the study of the virus's structural components, shedding light on the complex interplay between the viral capsid and envelope proteins.

Whether you're a seasoned immunologist or a rising star in the field, this recombinant protein can be the catalyst for your groundbreaking discoveries. Its potential applications span a wide range, from the development of novel diagnostic assays to the design of targeted therapeutic interventions. Unlock the versatile potential of this remarkable biochemical reagent and embark on a journey of scientific exploration that could redefine our understanding of HIV and pave the way for more effective treatments.

Product Features

• Recombinant fusion of HIV-1 gag p17-p24 and gp41-gp120 domains
• Meticulously crafted to ensure high purity and consistency
• Ideal for a wide range of immunology research applications
• Supports the development of innovative diagnostic tools and therapeutic strategies
• Contributes to a deeper understanding of the HIV virus's structure and function

Product Specifications

• Name: Recombinant HIV-1 gag p17-p24, gp41-gp120
• CAS: Not Available
• Ref #: 54-BITP1890
• Description: Not Found
• HS Code: 35040090
• Hazard Information: Irritant
• Category: Biochemicals and Reagents
• Sub-Category: Immunology Antibodies
• Long-Term Storage: None
• Notes: None

Unlock the Potential of Immunology Research

Embark on a journey of scientific discovery with our Recombinant HIV-1 gag p17-p24, gp41-gp120. This versatile biochemical reagent is a powerful tool in the hands of researchers dedicated to unraveling the complexities of the HIV virus and developing more effective diagnostic and therapeutic solutions.

Leverage the unique properties of this recombinant protein to explore the intricate structural and functional relationships within the HIV capsid and envelope. Utilize it as a key component in the development of cutting-edge immunoassays, enabling the early detection of HIV infection and the monitoring of disease progression.

Moreover, this recombinant protein can serve as a valuable starting point for the design of targeted therapeutic interventions, paving the way for more effective treatments that harness the power of the immune system to combat the HIV virus. Unlock the potential of this remarkable biochemical reagent and contribute to the advancement of HIV research, driving us closer to a future where the devastating impact of this disease is a distant memory.

Further Resources

To delve deeper into the technical specifications, applications, and safety guidelines of our Recombinant HIV-1